How much is NewAmsterdam Pharma worth in 2026?

NewAmsterdam Pharma has a current valuation of N/A based on their PIPE round and secondary market data.

How much funding has NewAmsterdam Pharma raised?

NewAmsterdam Pharma has raised N/A in total funding across 1 funding rounds.

NewAmsterdam Pharma

Drug Discovery

NewAmsterdam Pharma valuation and funding history | Last updated: November 15, 2022 | 1 funding rounds

Current Valuation

N/A

As of November 15, 2022

Total Funding Raised

N/A

Across 1 round

Last Round

PIPE

$235.0M

Last Funding

Nov 2022

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
November 15, 2022	PIPE	$235.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

NewAmsterdam Pharma is currently valued at N/A as of November 15, 2022.

Track NewAmsterdam Pharma Valuation Updates

Get notified when NewAmsterdam Pharma raises new funding or valuation changes

Explore More Data

Detailed analysis for NewAmsterdam Pharma

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock NewAmsterdam Pharma's valuation history, funding rounds, and growth metrics.

No credit card required

What is NewAmsterdam Pharma Worth in 2026?

NewAmsterdam Pharma is a leading private company in the Drug Discovery sector. Track NewAmsterdam Pharma's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How NewAmsterdam Pharma Valuation is Determined

Private company valuations like NewAmsterdam Pharma's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.